Hepatocellular Carcinoma: Symptoms, Causes, and Treatment

Hepatocellular carcinoma is the most common type of primary liver cancer. It often develops in people with long-term liver disease, but early detection and modern treatment options can improve outcomes.

Overview

Hepatocellular carcinoma, often shortened to HCC, is the most common form of primary liver cancer. Primary liver cancer begins in the liver itself, unlike cancer that has spread to the liver from another part of the body. HCC develops from hepatocytes, the main cells that make up liver tissue.

The liver plays many essential roles, including filtering blood, processing nutrients, helping with digestion, and storing energy. Because of this, diseases that affect the liver can have wide effects on overall health. In many cases, hepatocellular carcinoma develops in a liver that has already been damaged over time by chronic inflammation or scarring.

HCC may grow as a single tumor, several tumors, or more diffuse areas within the liver. Some people have no symptoms in the early stages, which is why regular screening is important for those at higher risk. When found early, treatment options may include surgery, local therapies, or liver transplantation.

Symptoms

Early hepatocellular carcinoma often causes no clear symptoms. This is one reason it may be detected during screening tests in people with cirrhosis or chronic viral hepatitis. As the tumor grows or liver function declines, symptoms may become more noticeable.

Possible symptoms of hepatocellular carcinoma can include pain or discomfort in the upper right side of the abdomen, unexplained weight loss, reduced appetite, fatigue, nausea, or a feeling of fullness after eating small amounts. Some people notice abdominal swelling due to fluid buildup, called ascites.

Signs of worsening liver function can also appear. These may include yellowing of the skin or eyes, known as jaundice, easy bruising, itching, pale stools, or dark urine. Because these symptoms can also occur in other liver conditions, a medical assessment is needed to find the cause.

• Upper abdominal pain or pressure
• Unintended weight loss
• Loss of appetite
• Persistent tiredness
• Abdominal swelling
• Jaundice

Causes and Risk Factors

Hepatocellular carcinoma usually develops after long-term injury to the liver. The strongest risk factor is cirrhosis, which means significant scarring of the liver. Cirrhosis can result from several causes, and not everyone with cirrhosis will develop HCC, but the risk is clearly higher.

Chronic hepatitis B and hepatitis C infections are major causes worldwide. Hepatitis B can increase the risk even without cirrhosis in some people. Another important cause is metabolic dysfunction-associated steatotic liver disease, previously called nonalcoholic fatty liver disease, especially when it progresses to inflammation and scarring. Long-term heavy alcohol use is also a common contributor to liver damage and cirrhosis.

Other risk factors include inherited liver disorders, exposure to aflatoxins in contaminated food, type 2 diabetes, obesity, and smoking. A personal history of advanced liver disease means careful follow-up is important. People who already live with cirrhosis or chronic liver infection may benefit from regular surveillance to look for changes early.

Diagnosis

Diagnosis begins with a medical history, physical examination, and review of liver disease risk factors. Doctors often order blood tests to evaluate liver function, clotting, and overall health. A blood marker called alpha-fetoprotein, or AFP, may be checked, but it does not confirm or rule out hepatocellular carcinoma on its own.

Imaging is central to diagnosis. Ultrasound may be used for surveillance, while contrast-enhanced CT or MRI can provide more detail and may show imaging patterns that strongly suggest HCC. In some patients with cirrhosis, these characteristic imaging findings are enough to make the diagnosis without a biopsy.

If imaging is not conclusive, a biopsy may be recommended to examine tissue under a microscope. Doctors also assess the stage of the cancer and the health of the liver, because both affect treatment planning. In many cases, evaluation is carried out by a multidisciplinary team that may include hepatologists, oncologists, surgeons, radiologists, and transplant specialists.

Treatment Options

Hepatocellular carcinoma treatment is individualized. The best approach depends on the size and number of tumors, whether blood vessels are involved, whether the cancer has spread, and how well the liver is functioning. A treatment plan also considers the person’s age, symptoms, and general health.

When the cancer is small and confined to the liver, surgery may offer the best chance of long-term control. This may involve removing part of the liver in selected patients with good remaining liver function. For some people, liver transplantation is an important option because it treats both the cancer and the underlying diseased liver.

Local therapies can be used when surgery is not suitable or while waiting for transplantation. These include tumor ablation, which destroys cancer using heat or other methods, and transarterial therapies that deliver treatment directly to the tumor’s blood supply. In selected cases, radiofrequency ablation or chemoembolization may be recommended. More advanced disease may be treated with systemic therapies such as targeted medicines or immunotherapy. Some patients also benefit from radiation oncology approaches as part of a broader plan.

Because liver cancer care is complex, treatment is often coordinated by a multidisciplinary team. Near the end of the care pathway, some patients seek treatment planning at centers such as Acibadem International, where multidisciplinary specialists in JCI-accredited hospitals diagnose and treat international patients with liver cancers.

Prevention and Self-care

Not all cases of hepatocellular carcinoma can be prevented, but lowering the risk of chronic liver damage can make a meaningful difference. Vaccination against hepatitis B is an important preventive step. Early diagnosis and treatment of hepatitis B or hepatitis C can also reduce liver inflammation and long-term complications.

Limiting alcohol, maintaining a healthy weight, and managing diabetes can help protect the liver. A balanced diet, regular physical activity, and avoiding smoking are practical ways to support overall liver health. People should also use medicines, supplements, and herbal products carefully, because some can harm the liver if misused.

For people at high risk, self-care includes keeping regular screening appointments. Doctors often recommend ultrasound with or without AFP testing every six months for certain groups, such as many patients with cirrhosis or chronic hepatitis B. Following a liver specialist’s advice is one of the most effective ways to detect problems early.

When to See a Doctor

A person should see a doctor if they have ongoing upper abdominal discomfort, unexplained weight loss, loss of appetite, jaundice, new abdominal swelling, or unusual fatigue. These symptoms do not always mean cancer, but they do need medical attention, especially in someone with known liver disease.

People with hepatitis B, hepatitis C, cirrhosis, or a strong history of liver disease should ask whether they need regular surveillance for hepatocellular carcinoma. Screening can help find tumors before symptoms appear, when more treatment options may be available. Prompt evaluation is also important if a routine scan or blood test shows an abnormal result.

Emergency care may be needed for severe confusion, vomiting blood, black stools, or sudden worsening of abdominal swelling, as these can suggest serious liver-related complications. In all cases, early medical advice supports safer diagnosis and timely treatment.

Frequently asked questions

Is hepatocellular carcinoma the same as liver cancer?

Hepatocellular carcinoma is the most common type of primary liver cancer, meaning it starts in the liver. However, the term liver cancer can also include other cancers that begin in the liver or cancers that spread there from other organs.

Can hepatocellular carcinoma develop without symptoms?

Yes. Many people have no symptoms in the early stages, especially if the cancer is found during routine surveillance. That is why screening is important for people with cirrhosis, chronic hepatitis B, or other significant risk factors.

Who is most at risk for hepatocellular carcinoma?

People with cirrhosis are at the highest risk. Chronic hepatitis B or hepatitis C, fatty liver disease, long-term heavy alcohol use, obesity, and diabetes can also increase risk.

How is hepatocellular carcinoma diagnosed?

Doctors usually combine a medical history, blood tests, and imaging such as ultrasound, CT, or MRI. In some cases, a biopsy is also needed if scans do not give a clear answer.

Is hepatocellular carcinoma treatable?

Yes, it is treatable, and the options depend on the stage of the cancer and the condition of the liver. Treatments may include surgery, liver transplantation, local tumor therapies, radiation-based treatment, and systemic medicines.

Can hepatocellular carcinoma be prevented?

Risk cannot always be removed completely, but prevention focuses on protecting the liver. Hepatitis B vaccination, treatment for viral hepatitis, limiting alcohol, maintaining a healthy weight, and regular surveillance for high-risk people can all help.

References

• World Health Organization
• American Cancer Society
• National Cancer Institute
• European Association for the Study of the Liver
• American Association for the Study of Liver Diseases

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.